Celularity - 53 Year Dividend History | CELU
Historical dividend payout and yield for Celularity (CELU) since 1971. The current TTM dividend payout for Celularity (CELU) as of November 19, 2024 is $0.00. The current dividend yield for Celularity as of November 19, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.064B |
$0.023B |
|
Celularity Inc. is a clinical stage biotechnology company. It involved in cellular medicine by developing off-the-shelf placental-derived allogeneic cell therapies, including unmodified NK cells, genetically-modified NK cells, T cells engineered with a CAR and mesenchymal-like adherent stromal cells targeting indications across cancer, infectious and degenerative diseases. Celularity Inc., formerly known as GX Acquisition Corp., is based in NEW YORK.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
